Top Cancer Stocks in Japan
Browse the largest Japan companies in the world ranked by their Market Capitalization. Global Cancer Companies in Japan market cap is $599.08M.
4 Nov 2024, 15:29 UTC
Companies: 9
🇯🇵1 |  | $9.58 | 11.37% | 143.51M | 42.07% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇯🇵2 |  | $3.71 | 2.93% | 107.10M | 88.21% | Outperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇯🇵3 |  | $0.34 | 9.09% | 56.85M | 4.35% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇯🇵4 |  | $1.29 | 8.88% | 56.04M | -11.11% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇯🇵5 |  | $0.26 | 2.78% | 50.16M | 60.87% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇯🇵6 |  | $4.19 | -4.53% | 49.29M | -4.84% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇯🇵7 |  | $2.80 | -5.29% | 47.99M | -23.05% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇯🇵8 |  | $3.85 | 1.48% | 21.81M | -44.86% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇯🇵9 |  | $0.35 | 2.04% | 20.99M | -41.86% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
